# Protalix BioTherapeutics, Inc.: Form 8-K, filed Apr 7, 2011

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2011-04-07
- Accepted by EDGAR: Apr 7, 2011, 16:05 ET
- Period: 2011-04-07
- Accession: 0000950123-11-033732
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000095012311033732/y04727e8vk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000095012311033732/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000095012311033732/y04727e8vk.htm

Filed Apr 7, 2011.
Source: SEC EDGAR, the filing index for accession 0000950123-11-033732. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
